Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label

被引:14
作者
Dutta, AK [1 ]
Fei, XS
Vaughan, RA
Gaffaney, JD
Wang, NN
Lever, JR
Reith, MEA
机构
[1] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA
[2] Univ N Dakota, Sch Med, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA
[3] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA
[4] Univ Illinois, DBTS, Peoria, IL USA
关键词
dopamine transporter; GBR; 12909; photoaffinity ligand; structure activity relationship study;
D O I
10.1016/S0024-3205(01)00981-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The dopamine transporter (DAT) has been implicated strongly in cocaine's reinforcing effects. Many derivatives of piperidine analogs of GBR 12909 have been developed and were found to be quite potent and selective for the DAT. In this regard, most of these derivatives were found to be much more selective for the DAT than conventional GBR compounds e.g. GBR 12909 when their selectivity was compared with the serotonin transporter (SERT). A brief structure-activity relationship (SAR) study has been carried out in the development of a novel photoaffinity ligand which illustrated the effect of the presence of a sterically bulky iodine atom next to the azido group in activity and selectivity for the DAT. This SAR study also led to the development of the compound 4 which is one of the most potent and selective blockers for the DAT known today. The photoaffinity ligand [I-125]AD-96-129 was incorporated into the DAT molecule as was demonstrated by immunoprecipitation with serum 16 which is specific for DAT. This photolabeling was antagonized by DAT-specific blockers and was unaffected by specific SERT and norepinephrine transporter (NET) blockers indicating interaction of this novel ligand with the DAT. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1839 / 1849
页数:11
相关论文
共 32 条
[2]   COCAINE RECEPTOR - BIOCHEMICAL-CHARACTERIZATION AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF COCAINE ANALOGS AT THE DOPAMINE TRANSPORTER [J].
CARROLL, FI ;
LEWIN, AH ;
BOJA, JW ;
KUHAR, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (06) :969-981
[3]   SYNTHESIS AND PHARMACOLOGY OF IRREVERSIBLE AFFINITY LABELS AS POTENTIAL COCAINE ANTAGONISTS - ARYL 1,4-DIALKYLPIPERAZINES RELATED TO GBR-12783 [J].
DEUTSCH, HM ;
SCHWERI, MM ;
CULBERTSON, CT ;
ZALKOW, LH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 220 (2-3) :173-180
[4]   Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine for the dopamine transporter: Effect of different aromatic substitutions on their affinity and selectivity [J].
Dutta, AK ;
Coffey, LL ;
Reith, MEA .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (01) :35-43
[5]   Structure-activity relationship studies of novel 4-[2-[bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl)piperidine analogs: Synthesis and biological evaluation at the dopamine and serotonin transporter sites [J].
Dutta, AK ;
Xu, C ;
Reith, MEA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :749-756
[6]   Potent and selective ligands for the dopamine transporter (DAT): Structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues [J].
Dutta, AK ;
Coffey, LL ;
Reith, MEA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (05) :699-705
[7]  
DUTTA AK, 1993, MED CHEM RES, V3, P209
[8]   PHENCYCLIDINE BINDING-SITES IN THE NUCLEUS ACCUMBENS AND PHENCYCLIDINE-INDUCED HYPERACTIVITY ARE DECREASED FOLLOWING LESIONS OF THE MESOLIMBIC DOPAMINE SYSTEM [J].
FRENCH, ED ;
PILAPIL, C ;
QUIRION, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (1-2) :1-9
[9]  
GIROS B, 1994, J BIOL CHEM, V269, P15985
[10]  
GRIGORIADIS DE, 1989, J NEUROSCI, V9, P2664